« The Ruesch Center

John L. Marshall, MD, is director of the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer; associate director for clinical care at the Lombardi Comprehensive Cancer Center; and professor and chief of the Division of Hematology/Oncology at Georgetown University, Washington, DC. A global leader in research for colon cancer and other GI cancers, he is the principal investigator of over 150 clinical trials.

+ Add To Email Alerts

• No-Visitor Policies Are Bad Medicine   Hospitals during the pandemic are the 'loneliest place on Earth.' Oncologist John Marshall explains why patients -- and providers -- benefit from the presence of visitors.
  Medscape Oncology, August 2020
• COVID-19 Has Strengthened Pharma's Negotiating Hand   Dr John Marshall discusses the impact of COVID-19 on discussions related to drug prices.
  Medscape Oncology, July 2020
• Practice-Changing GI Cancer Highlights From Virtual ASCO 2020   Gastrointestinal cancer expert Dr John Marshall gives his high-level overview of the most important developments in GI cancers, presented at the recent virtual ASCO 2020 meeting.
  Medscape Oncology, June 2020
• Taking a Break From the Medical 'Service Industry'   John Marshall discusses his excitement and apprehension for his upcoming sabbatical.
  Medscape Oncology, June 2019
• Molecular Profiling Is Key to GI Cancer Treatment Success   John Marshall reports on treatment trials in gastric, pancreatic, and colon cancers, from the 2019 GI Cancers Symposium.
  Medscape Oncology, February 2019
• Hype, Fear of Failure Driving Immunotherapy 'Hail Mary' Treatments   John Marshall speaks with Leonard Saltz and Tanios Bekaii-Saab about the destructive trend of trying experimental drugs before having the data, and the new 'right to try' law.
  Medscape Oncology, June 2018

More